期刊文献+

联用沙丁胺醇和溴化异丙托品雾化吸入对COPD急性加重期的治疗作用 被引量:2

联用沙丁胺醇和溴化异丙托品雾化吸入对COPD急性加重期的治疗作用
下载PDF
导出
摘要 目的探讨沙丁胺醇和溴化异丙托品联合雾化吸入对慢性阻塞性肺疾病(COPD)急性加重期患者肺功能及动脉血气的影响。方法 106例COPD急性加重期患者随机分为对照组(52例)和实验组(54例)。2组均采用常规治疗,实验组加用溴化异丙托品和沙丁胺醇平静呼吸时氧气雾化吸入,每天2次。2组患者均于治疗开始前及治疗第7天后测定肺功能及动脉血气分析。结果实验组肺功能及动脉血气较治疗前均有明显改善(P<0.05)。结论联合氧气雾化吸人溴化异丙托品和沙丁胺醇对COPD急性加重期患者的肺功能及动脉血气分析有明显的改善作用。 Objective Salbutamol, bromlnated isopropyl tetramin methenamlne joint aerosol inhalation of chronic obstructive pulmonary disease (COPD) patients with acute exacerbations period lung function and arterial blood gas influence.Methods Acute exacerbations of 106 patients COPD patients were randomly divided into the control group (52 cases) and group (n=54). Both groups using conventional treatment, group odd with brominated isopropyl tetramin methenamlne, sulbutomol calm breathing oxygen atomization sucked, 2 times daily. Two groups of patients before the start of treatment in all 7 days after treatment and determination of lung function and arterial blood gas.Results The lung function and arterial blood gas relatively before treatment will be improved obviously (P〈0.05).Conclusion Combined oxygen atomization sucked bromlnated isopropyl tetramin methenamlne and salbutomol of COPD patients with acute exacerbations period of pulmonary function and natural role has improved remarkably.
作者 吴万春
出处 《中国卫生产业》 2011年第06Z期30-30,32,共2页 China Health Industry
关键词 慢性阻塞性肺疾病 加重期 支气管扩张剂 血气分析 Chronic obstructive pulmonary disease Aggravating period Bronchodiistors Blood gas analysis
  • 相关文献

参考文献3

二级参考文献15

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Mahlfr DA. The effect of inhaled beta 2 - agonists on clinical outcomes in chronic obstructive pulmonary disease. Journal of Allergy & Clinical Immunology,2002,110(6 Suppl): s298 - s303.
  • 3Dimarco F, Milic- Emili J, Boveri B, et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. European Respiratory Journal,2003,21 (1) :86 - 94.
  • 4Levin DC,Little KS,Laughlkn KR, et al. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. American Joumal of Medicine,1996,100(1A): s40 - s48.
  • 5Dorinsky PM, Reisner C, Ferguson GT, et al. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. Chest, 1999,115(4): 966 - 971.
  • 6Friedman M,Serby CW, Menjoge SS,et al. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest, 1999,115(3):635- 641.
  • 7Oga T, Nishimura K, Tsukino M, et al. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest,2003,123(6):1 810-1 816.
  • 8冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 9GOLD Executive Committee[DB/OL]. Guidelines: Global Strategy for Diagnosis, Management, and Prevention of COPD,November 2006 [ 2006-11-18 ]. http://www.goldcopd.com/Guidelineitem. asp? 11 =2&12 = 1&intId =989.
  • 10Celli BR, MacNee W, Committee members. Standard for the diagnosis and treatment of patients with COPD : a summary of the ATS/ERS position paper. Eur Respir J, 2004,23:932-946.

共引文献1810

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部